OIG: Drugmakers should disclose wholesale prices to CMS

04/27/2011 | Hill, The

Medicare could save $4.4 million each year by reducing reimbursement for drugs covered under Part B that have an average sale price at least 5% more than the wholesale price, according to an HHS Inspector General's report. The CMS responded by saying doing so would violate a court order against disclosing wholesale prices to the public.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ